Takeda Pharmaceutical Co Ltd
F:TKD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Takeda Pharmaceutical Co Ltd
F:TKD
|
JP |
|
U
|
Unum Group
XMUN:UUM
|
US |
|
Q linea AB
F:3F80
|
SE |
|
B
|
BYD Co Ltd
XMUN:BY6
|
CN |
|
C
|
CACI International Inc
F:CA8A
|
US |
|
Grupo Mexico SAB de CV
F:4GE
|
MX |
|
M
|
McEwen Mining Inc
F:US8A
|
CA |
|
J
|
JinkoSolar Holding Co Ltd
XMUN:ZJS1
|
CN |
|
Spinnova Oyj
F:9HP
|
FI |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
F:AIL
|
FR |
|
Siloam International Hospitals Tbk PT
F:2LS
|
ID |
|
Virgin Australia Holdings Ltd
F:VBL0
|
AU |
|
U
|
United Labels AG
XMUN:ULC
|
DE |
|
U
|
United Bankshares Inc
F:UNK
|
US |
|
Embotelladora Andina SA
F:AKOB
|
CL |
|
M
|
MKS Instruments Inc
XMUN:MKT
|
US |
|
A
|
ADTRAN Holdings Inc
XBER:QH9
|
US |
|
M
|
Magle Chemoswed Holding AB
F:52X
|
SE |
|
P
|
Puma SE
OTC:PUMSY
|
DE |
|
Valens Semiconductor Ltd
NYSE:VLN
|
IL |
Wall St Price Targets
TKD Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for TKD is 29.34 EUR with a low forecast of 24.26 EUR and a high forecast of 37.83 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TKD's stock price target?
Price Target
29.34
EUR
According to Wall Street analysts, the average 1-year price target for TKD is 29.34 EUR with a low forecast of 24.26 EUR and a high forecast of 37.83 EUR.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 2 years is -5%.
What is the Net Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
44%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 44%.
